Medical - Devices
Compare Stocks
3 / 10Stock Comparison
QIPT vs HCSG vs EHAB
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
QIPT vs HCSG vs EHAB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Medical - Devices | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $161M | $1.60B | $706M |
| Revenue (TTM) | $287M | $1.84B | $1.06B |
| Net Income (TTM) | $-11M | $59M | $-3M |
| Gross Margin | 84.5% | 13.3% | 34.5% |
| Operating Margin | -0.8% | 3.0% | 7.2% |
| Forward P/E | — | 20.8x | 22.8x |
| Total Debt | $119M | $25M | $500M |
| Cash & Equiv. | $13M | $161M | $44M |
QIPT vs HCSG vs EHAB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 22 | Mar 26 | Return |
|---|---|---|---|
| Quipt Home Medical … (QIPT) | 100 | 79.0 | -21.0% |
| Healthcare Services… (HCSG) | 100 | 125.0 | +25.0% |
| Enhabit, Inc. (EHAB) | 100 | 59.3 | -40.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: QIPT vs HCSG vs EHAB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
QIPT is the clearest fit if your priority is momentum.
- +70.6% vs HCSG's +55.8%
HCSG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 20 yrs, beta 1.12
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- -26.8% 10Y total return vs QIPT's 351.7%
EHAB is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.44, Low D/E 88.6%, current ratio 1.63x
- Beta 0.44, current ratio 1.63x
- Beta 0.44 vs HCSG's 1.12
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs QIPT's -0.2% | |
| Value | Lower P/E (20.8x vs 22.8x) | |
| Quality / Margins | 3.2% margin vs QIPT's -3.7% | |
| Stability / Safety | Beta 0.44 vs HCSG's 1.12 | |
| Dividends | Tie | None of these 3 stocks pay a meaningful dividend |
| Momentum (1Y) | +70.6% vs HCSG's +55.8% | |
| Efficiency (ROA) | 7.3% ROA vs QIPT's -5.3%, ROIC 9.0% vs -1.4% |
QIPT vs HCSG vs EHAB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
QIPT vs HCSG vs EHAB — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
QIPT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HCSG is the larger business by revenue, generating $1.8B annually — 6.4x QIPT's $287M. HCSG is the more profitable business, keeping 3.2% of every revenue dollar as net income compared to QIPT's -3.7%. On growth, QIPT holds the edge at +34.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $287M | $1.8B | $1.1B |
| EBITDAEarnings before interest/tax | $46M | $72M | $98M |
| Net IncomeAfter-tax profit | -$11M | $59M | -$3M |
| Free Cash FlowCash after capex | $27M | $139M | $81M |
| Gross MarginGross profit ÷ Revenue | +84.5% | +13.3% | +34.5% |
| Operating MarginEBIT ÷ Revenue | -0.8% | +3.0% | +7.2% |
| Net MarginNet income ÷ Revenue | -3.7% | +3.2% | -0.3% |
| FCF MarginFCF ÷ Revenue | +9.3% | +7.6% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +34.0% | +6.6% | +1.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.8% | +175.0% | +2.9% |
Valuation Metrics
QIPT leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, QIPT's 6.4x EV/EBITDA is more attractive than HCSG's 22.4x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $161M | $1.6B | $706M |
| Enterprise ValueMkt cap + debt − cash | $267M | $1.5B | $1.2B |
| Trailing P/EPrice ÷ TTM EPS | -14.60x | 27.54x | -152.10x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.83x | 22.84x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — |
| EV / EBITDAEnterprise value multiple | 6.37x | 22.38x | 13.47x |
| Price / SalesMarket cap ÷ Revenue | 0.66x | 0.87x | 0.67x |
| Price / BookPrice ÷ Book value/share | 1.41x | 3.19x | 1.24x |
| Price / FCFMarket cap ÷ FCF | 6.34x | 11.49x | 10.73x |
Profitability & Efficiency
HCSG leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-10 for QIPT. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to QIPT's 1.06x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs QIPT's 4/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -9.5% | +11.8% | -0.6% |
| ROA (TTM)Return on assets | -5.3% | +7.3% | -0.3% |
| ROICReturn on invested capital | -1.4% | +9.0% | +4.5% |
| ROCEReturn on capital employed | -1.8% | +7.7% | +6.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 6 |
| Debt / EquityFinancial leverage | 1.06x | 0.05x | 0.89x |
| Net DebtTotal debt minus cash | $7M | -$136M | $456M |
| Cash & Equiv.Liquid assets | $13M | $161M | $44M |
| Total DebtShort + long-term debt | $119M | $25M | $500M |
| Interest CoverageEBIT ÷ Interest expense | -0.30x | 33.02x | 0.83x |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HCSG five years ago would be worth $7,888 today (with dividends reinvested), compared to $5,497 for QIPT. Over the past 12 months, QIPT leads with a +70.6% total return vs HCSG's +55.8%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs QIPT's -16.1% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +3.4% | +28.6% | +51.6% |
| 1-Year ReturnPast 12 months | +70.6% | +55.8% | +68.0% |
| 3-Year ReturnCumulative with dividends | -40.9% | +48.6% | +2.1% |
| 5-Year ReturnCumulative with dividends | -45.0% | -21.1% | -44.9% |
| 10-Year ReturnCumulative with dividends | +351.7% | -26.8% | -44.9% |
| CAGR (3Y)Annualised 3-year return | -16.1% | +14.1% | +0.7% |
Risk & Volatility
QIPT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
QIPT is the less volatile stock with a -0.03 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. QIPT currently trades 100.0% from its 52-week high vs HCSG's 91.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.03x | 1.12x | 0.44x |
| 52-Week HighHighest price in past year | $3.65 | $24.39 | $14.22 |
| 52-Week LowLowest price in past year | $1.35 | $12.66 | $6.47 |
| % of 52W HighCurrent price vs 52-week peak | +100.0% | +91.5% | +96.9% |
| RSI (14)Momentum oscillator 0–100 | 76.6 | 61.8 | 58.6 |
| Avg Volume (50D)Average daily shares traded | 594K | 676K | 1.3M |
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: QIPT as "Buy", HCSG as "Hold", EHAB as "Hold". Consensus price targets imply 9.8% upside for HCSG (target: $25) vs -1.8% for EHAB (target: $14).
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $3.65 | $24.50 | $13.53 |
| # AnalystsCovering analysts | 2 | 15 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — | — |
| Dividend StreakConsecutive years of raises | — | 20 | 0 |
| Dividend / ShareAnnual DPS | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +3.9% | 0.0% |
QIPT leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). HCSG leads in 3 (Profitability & Efficiency, Total Returns).
QIPT vs HCSG vs EHAB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is QIPT or HCSG or EHAB a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -0. 2% for Quipt Home Medical Corp. (QIPT). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 27. 5x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate Quipt Home Medical Corp. (QIPT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — QIPT or HCSG or EHAB?
On forward P/E, Healthcare Services Group, Inc.
is actually cheaper at 20. 8x.
03Which is the better long-term investment — QIPT or HCSG or EHAB?
Over the past 5 years, Healthcare Services Group, Inc.
(HCSG) delivered a total return of -21. 1%, compared to -45. 0% for Quipt Home Medical Corp. (QIPT). Over 10 years, the gap is even starker: QIPT returned +351. 7% versus EHAB's -44. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — QIPT or HCSG or EHAB?
By beta (market sensitivity over 5 years), Quipt Home Medical Corp.
(QIPT) is the lower-risk stock at -0. 03β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately -3328% more volatile than QIPT relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 106% for Quipt Home Medical Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — QIPT or HCSG or EHAB?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus -0. 2% for Quipt Home Medical Corp. (QIPT). On earnings-per-share growth, the picture is similar: Enhabit, Inc. grew EPS 97. 1% year-over-year, compared to -56. 3% for Quipt Home Medical Corp.. Over a 3-year CAGR, QIPT leads at 20. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — QIPT or HCSG or EHAB?
Healthcare Services Group, Inc.
(HCSG) is the more profitable company, earning 3. 2% net margin versus -4. 4% for Quipt Home Medical Corp. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EHAB leads at 6. 0% versus -1. 6% for QIPT. At the gross margin level — before operating expenses — QIPT leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is QIPT or HCSG or EHAB more undervalued right now?
On forward earnings alone, Healthcare Services Group, Inc.
(HCSG) trades at 20. 8x forward P/E versus 22. 8x for Enhabit, Inc. — 2. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HCSG: 9. 8% to $24. 50.
08Which pays a better dividend — QIPT or HCSG or EHAB?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is QIPT or HCSG or EHAB better for a retirement portfolio?
For long-horizon retirement investors, Quipt Home Medical Corp.
(QIPT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 03), +351. 7% 10Y return). Both have compounded well over 10 years (QIPT: +351. 7%, HCSG: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between QIPT and HCSG and EHAB?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.